GARDASIL 9 30 ug/.5mL

GARDASIL 9 is a 9-valent HPV vaccine designed to help prevent certain HPV-related conditions. This recombinant vaccine is administered intramuscularly and is available in single-dose vials.

GARDASIL 9 is used to help prevent infections caused by nine types of human papillomavirus (HPV). These types of HPV are associated with various health conditions, including cervical, vulvar, vaginal, and anal cancers, as well as genital warts. The vaccine is intended for use in individuals to help reduce the risk of these HPV-related conditions.

Common effects of GARDASIL 9 may include pain, swelling, or redness at the injection site. Some individuals may also experience headaches, fatigue, or mild fever following vaccination. These effects are generally mild and temporary.

GARDASIL 9 should be administered by healthcare professionals. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to discuss any medical conditions or allergies with a healthcare provider before receiving the vaccine.

GARDASIL 9 is a vaccine and typically does not interact with other medications. However, it is important to inform healthcare providers about all current medications and health conditions before receiving the vaccine. Alcohol and other substances generally do not affect the vaccine's efficacy.